Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects By: MarketWatch December 01, 2023 at 07:35 AM EST Pfizer's drug helped patients lose weight but also caused nausea and diarrhea. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Pfizer
